Life Sciences

Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.



Sign up for a 7-day FREE trial today!



Latest News in Life Sciences

  • July 23, 2019

    $50M IRS Claim Holds Up Avadel Pharma Ch. 11 Confirmation

    Attorneys for bankrupt drugmaker Avadel Specialty Pharmaceuticals LLC said Tuesday that a combined hearing on its Chapter 11 plan and disclosure statement would have to wait after the Internal Revenue Service filed a $50 million claim against the estate related to outstanding tax liabilities.

  • July 23, 2019

    Corcept Wants Sun's Cushing's Syndrome Drug Blocked

    Corcept Therapeutics Inc. has asked a New Jersey federal judge to block Sun Pharma's planned generic version of its flagship Cushing's syndrome medication Korlym, claiming three valid patents will be infringed.

  • July 22, 2019

    Amgen, Allergan Launch 2 Biosimilars With Court's Blessing

    Amgen and Allergan have started selling their biosimilar versions of Genentech's blockbuster cancer treatments Avastin and Herceptin in the U.S., announcing the launch immediately after a Delaware federal judge refused to block the sales.

  • July 22, 2019

    Calif. Expert Says J&J's 'Propaganda' Misled Mesh Patients

    A consumer behavior expert testified Monday that a "propaganda analysis" he conducted on hundreds of Johnson & Johnson marketing materials showed that they would have misled consumers by downplaying the risks of surgical mesh devices, during California's trial alleging the industry titan falsely marketed the mesh products.

  • July 22, 2019

    DOJ Errors Doom Suboxone Film Fraud Case, Indivior Says

    Indivior has urged a federal judge to toss an indictment accusing it of misrepresenting the risk of abuse posed to children by its opioid-dependence treatment Suboxone Film, claiming federal prosecutors included inadmissible references to a doctor's health care fraud convictions and possibly even intentionally misled the grand jury.

See more Life Sciences news

Life Sciences

Areas of Coverage

  • AGENCIES
  • U.S. Consumer Product Safety Commission
  • U.S. Food and Drug Administration
  • U.S. Patent and Trademark Office
  • U.S. International Trade Commission
  • POLICY & REGULATION
  • Affordable Care Act
  • Federal Food, Drug, and Cosmetic Act
  • Antitrust and consumer protection controls
  • Drug and medical device lobbying
  • State and international life sciences legislation and regulation
  • ENFORCEMENT
  • Drug and medical device recalls
  • Drug safety actions
  • Pay-for-delay investigations
  • Merger reviews
  • LITIGATION
  • Patent disputes, including
  • Abbreviated New Drug Application litigation
  • Section 301 cases
  • Product safety suits over drugs and medical devices, including off-label marketing and failure-to-warn claims
  • Consumer litigation and class actions
  • Fraud and compliance suits
  • Antitrust disputes
  • Labor and employment suits
  • Shareholder and corporate governance disputes
  • Bankruptcy proceedings
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures
  • Share buybacks and stock splits
  • Private equity deals
  • Patent-licensing agreements
  • PROFILES
  • Personnel moves
  • Profiles of life sciences practice groups

Readership

  • Life sciences lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the drug, biotechnology, and medical device industries
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals